SCM
KYTX icon

Sterling Capital Management’s Kyverna Therapeutics KYTX Stock Holding History

Sterling Capital Management’s Portfolio KYTX Stock Details KYTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.99K Buy
+785
New +$6.97K ﹤0.01% 2428
2025
Q2 		– Sell
-186
Closed -$359 – 3420
2025
Q1 		$359 Sell
186
-47
-20% -$139 ﹤0.01% 3012
2024
Q4 		$871 Buy
233
+201
+628% +$963 ﹤0.01% 2967
2024
Q3 		$156 Buy
+32
New +$247 ﹤0.01% 3144

Other funds holding KYTX

YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
WB
WesBanco Bank Wheeling, West Virginia $4.02B AUM 32.62% 1-Year Est. Return
ACM
ACT Capital Management Wayne, Pennsylvania $153M AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
EI
Ethic Inc New York $8.02B AUM 45.39% 1-Year Est. Return
SIC
Samalin Investment Counsel Chappaqua, New York $320M AUM 20.87% 1-Year Est. Return
CAI
Capital Advisors Inc Tulsa, Oklahoma $6.8B AUM 26.96% 1-Year Est. Return

Sterling Capital Management's KYTX Position: Q2 2026 in Review

Sterling Capital Management opened a new position in Kyverna Therapeutics (KYTX) in Q2 2026: 785 shares worth $6.99K. The stake represents ﹤0.01% of the portfolio and ranks #2428 among its holdings. This is a return to the name: Sterling Capital Management previously reported a position in KYTX as recently as Q1 2025.

Sterling Capital Management first reported a position in KYTX in Q3 2024 and has held it in 4 quarters since. 21 funds tracked by Wall St. Rank hold KYTX as of Q2 2026.

  • Sterling Capital Management held 785 shares of Kyverna Therapeutics worth $6.99K as of Q2 2026.
  • Kyverna Therapeutics was a new Sterling Capital Management position in Q2 2026.
  • Kyverna Therapeutics made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #2428 holding.
  • Sterling Capital Management first reported a position in Kyverna Therapeutics in Q3 2024 and has held it in 4 quarters since.
  • 21 funds tracked by Wall St. Rank held Kyverna Therapeutics as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.